阿尔茨海默病遗传风险与淀粉样蛋白沉积遗传风险不同
该研究利用阿尔茨海默病神经影像学倡议队列的公开数据,检验多基因风险评分(PRS)对阿尔茨海默病(AD)、轻度认知障碍(MCI)和淀粉样蛋白沉积风险的预测准确性,并分别纳入和排除APOE基因型。通路特异性PRS分析中,蛋白-脂质复合物与AD和淀粉样蛋白沉积关联最强,即使去除APOE区域基因后仍显著(p=0.0055和p=0.0079)。
要点
- AD和MCI风险由APOE与PRS共同预测,淀粉样蛋白沉积仅由APOE预测。
- MCI且淀粉样蛋白阳性者进展为AD的风险由PRS在APOE之上额外预测。
- 蛋白-脂质复合物通路PRS与AD和淀粉样蛋白沉积关联最强,去除APOE区域后仍显著。
核心结论
- APOE主要促进淀粉样蛋白沉积,而PRS影响进一步转化为AD的风险。
研究设计与样本
- 利用阿尔茨海默病神经影像学倡议队列的公开数据集,包含广泛表型数据,检验PRS对AD、MCI和淀粉样蛋白沉积风险的预测准确性,分别纳入和排除APOE基因型。
主要发现
- 通路特异性PRS分析中,蛋白-脂质复合物与AD和淀粉样蛋白沉积关联最强,去除APOE区域基因后p=0.0055和p=0.0079。
临床怎么用
- 对于MCI且淀粉样蛋白阳性的患者,可考虑使用PRS评估进一步转化为AD的风险。
- 淀粉样蛋白沉积风险预测可主要依据APOE基因型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Alzheimer disease (AD) is the most common form of dementia and is responsible for a huge and growing health care burden in the developed and developing world. The polygenic risk score (PRS) approach has shown 75 to 84% prediction accuracy of identifying individuals with AD risk. METHODS: In this study, we tested the prediction accuracy of AD, mild cognitive impairment (MCI), and amyloid deposition risks with PRS, including and excluding APOE genotypes in a large publicly available dataset with extensive phenotypic data, the Alzheimer's Disease Neuroimaging Initiative cohort. Among MCI individuals with amyloid-positive status, we examined PRS prediction accuracy in those who converted to AD. In addition, we divided polygenic risk score by biological pathways and tested them independently for distinguishing between AD, MCI, and amyloid deposition. RESULTS: We found that AD and MCI are predicted by both APOE genotype and PRS (area under the curve [AUC] = 0.82% and 68%, respectively). Amyloid deposition is predicted by APOE only (AUC = 79%). Further progression to AD of individuals with MCI and amyloid-positive status is predicted by PRS over and above APOE (AUC = 67%). In pathway-specific PRS analyses, the protein-lipid complex has the strongest association with AD and amyloid deposition even when genes in the APOE region were removed (p = 0.0055 and p = 0.0079, respectively). INTERPRETATION: The results showed different pattern of APOE contribution in PRS risk predictions of AD/MCI and amyloid deposition. Our study suggests that APOE mostly contributes to amyloid accumulation and the PRS affects risk of further conversion to AD. ANN NEUROL 2019;86:427-435.
引用
- Leonenko G, Shoai M, Bellou E, et al. Genetic risk for alzheimer disease is distinct from genetic risk for amyloid deposition. Ann Neurol. 2019. PMID: 31199530. doi:10.1002/ana.25530
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。